![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 9, 7136-7143, March 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
§§
From the A deficiency of 3-phosphoglycerate dehydrogenase
(PHGDH) is a disorder of serine biosynthesis identified in children
with congenital microcephaly, seizures, and severe psychomotor
retardation. We report here the identification of the 1468G
Department of Biochemistry and Medical
Genetics and ** Departments of Internal Medicine and
Immunology, University of Manitoba, Winnipeg, Manitoba R3E 0W3, Canada,
the ¶ Division of Medical Genetics, Shriver Center for Mental
Retardation, Waltham, Massachusetts 02452, the
Departments of
Neurology and Pediatrics, University of Utah School of Medicine, Salt
Lake City, Utah 84132, and 
Harvard Medical
School and Massachusetts General Hospital,
Boston, Massachusetts 02114
A (V490M)
mutation of this gene in two siblings of an Ashkenazi Jewish family,
providing further evidence that the V490M mutation is a common,
panethnic cause of this deficiency. Using a novel, DNA-based diagnostic test, the mutation was not detected in 400 non-Jewish controls; one
heterozygote was found among 400 persons of Ashkenazi Jewish ethnicity.
Extensive biochemical studies were undertaken to characterize the
effect of this mutation on enzyme activity, turnover, and stability.
The V490M PHGDH yielded less than 35% of the activity observed for the
wild-type enzyme when overexpressed by transient transfection or when
comparing the endogenous activity in fibroblast cells from the patients
with controls. Immunoblotting studies showed a comparable reduction in
the level of immunoreactive PHGDH in cells expressing the mutant
enzyme. Pulse-chase experiments with metabolically labeled PHGDH
indicated that this resulted from an increased rate of degradation of
the mutant enzyme following its synthesis. Thermolability analyses of
mutant and wild-type enzyme activity revealed no significant
differences. While others have proposed that the V490M mutation
decreases the Vmax of the enzyme, we conclude
that this mutation impairs the folding and/or assembly of PHGDH but has
minimal effects on the activity or stability of that portion of the
V490M mutant that reaches a mature conformation.
This article has been cited by other articles:
![]() |
M. L Nagpal, Y. Chen, and T. Lin Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation J. Endocrinol., December 1, 2004; 183(3): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |